nitrites has been researched along with Pulmonary Embolism in 11 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that pretreatment with atorvastatin attenuates APE-induced pulmonary hypertension and increases 24-hr survival rate by mechanisms that result in attenuated increases in lung activated MMP-9 after APE." | 7.74 | Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. ( Alves-Filho, JC; Cunha, FQ; Figueiredo-Lopes, L; Gerlach, RF; Semprini, MC; Souza-Costa, DC; Tanus-Santos, JE, 2007) |
| "Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia." | 5.51 | Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism. ( Gustafsson, LE; Nilsson, KF, 2019) |
| "Sildenafil attenuates acute pulmonary embolism-induced pulmonary hypertension." | 5.33 | Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. ( Dias-Junior, CA; Evora, PR; Moreno, H; Souza-Silva, AR; Tanus-Santos, JE; Uzuelli, JA, 2005) |
| "These results suggest that pretreatment with atorvastatin attenuates APE-induced pulmonary hypertension and increases 24-hr survival rate by mechanisms that result in attenuated increases in lung activated MMP-9 after APE." | 3.74 | Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. ( Alves-Filho, JC; Cunha, FQ; Figueiredo-Lopes, L; Gerlach, RF; Semprini, MC; Souza-Costa, DC; Tanus-Santos, JE, 2007) |
| "Acute pulmonary embolism may cause right heart failure due to increased pulmonary vascular resistance and arterial hypoxemia." | 1.51 | Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism. ( Gustafsson, LE; Nilsson, KF, 2019) |
| " While sildenafil produced no change in plasma NOx concentrations, S-methylisothiourea alone or combined with sildenafil blunted APE-induced increases in NOx concentrations." | 1.36 | Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. ( Dias-Junior, CA; Montenegro, MF; Neto-Neves, EM; Tanus-Santos, JE, 2010) |
| "The diagnosis of acute pulmonary thromboembolism (APT) and its severity is challenging." | 1.35 | Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism. ( Dias-Junior, CA; Gerlach, RF; Izidoro-Toledo, TC; Tanus-Santos, JE; Uzuelli, JA, 2009) |
| "Atorvastatin was ineffective." | 1.34 | NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. ( Caracchini, R; Gresele, P; Guglielmini, G; Guzzetta, M; Impagnatiello, F; Momi, S; Monopoli, A; Olivieri, R, 2007) |
| "In a mouse model of platelet pulmonary thromboembolism, induced by the i." | 1.33 | A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. ( Caracchini, R; Colucci, M; Giannini, S; Gresele, P; Guglielmini, G; Momi, S; Monopoli, A; Ongini, E; Rossiello, MR; Semeraro, N, 2005) |
| "Sildenafil attenuates acute pulmonary embolism-induced pulmonary hypertension." | 1.33 | Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. ( Dias-Junior, CA; Evora, PR; Moreno, H; Souza-Silva, AR; Tanus-Santos, JE; Uzuelli, JA, 2005) |
| "Sildenafil attenuates acute pulmonary embolism (APE)-induced pulmonary hypertension." | 1.33 | Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. ( Dias-Junior, CA; Tanus-Santos, JE, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nilsson, KF | 1 |
| Gustafsson, LE | 1 |
| Dias-Junior, CA | 6 |
| Cau, SB | 1 |
| Oliveira, AM | 1 |
| Castro, MM | 1 |
| Montenegro, MF | 2 |
| Gerlach, RF | 3 |
| Tanus-Santos, JE | 7 |
| Uzuelli, JA | 2 |
| Izidoro-Toledo, TC | 1 |
| Neto-Neves, EM | 1 |
| Rossiello, MR | 1 |
| Momi, S | 2 |
| Caracchini, R | 2 |
| Giannini, S | 1 |
| Guglielmini, G | 2 |
| Monopoli, A | 2 |
| Ongini, E | 1 |
| Semeraro, N | 1 |
| Colucci, M | 1 |
| Gresele, P | 2 |
| Souza-Silva, AR | 1 |
| Moreno, H | 1 |
| Evora, PR | 1 |
| Souza-Costa, DC | 1 |
| Figueiredo-Lopes, L | 1 |
| Alves-Filho, JC | 1 |
| Semprini, MC | 1 |
| Cunha, FQ | 1 |
| Keymel, S | 1 |
| Rassaf, T | 1 |
| Kelm, M | 1 |
| Gladwin, MT | 1 |
| Impagnatiello, F | 1 |
| Guzzetta, M | 1 |
| Olivieri, R | 1 |
11 other studies available for nitrites and Pulmonary Embolism
| Article | Year |
|---|---|
Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.
Topics: Animals; Hypertension, Pulmonary; Male; Nitric Oxide; Nitric Oxide Donors; Nitrites; Propylene Glyco | 2019 |
Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress.
Topics: Acute Disease; Animals; Disease Models, Animal; Dogs; Female; Humans; Male; Matrix Metalloproteinase | 2009 |
Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism.
Topics: Animals; Blood Pressure; Cell-Free System; DNA; Dogs; Female; Male; Nitrites; Pulmonary Artery; Pulm | 2009 |
Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism.
Topics: Acute Disease; Animals; Dogs; Female; Hemodynamics; Isothiuronium; Male; Nitrates; Nitric Oxide; Nit | 2010 |
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
Topics: Animals; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro | 2005 |
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension.
Topics: Acute Disease; Analysis of Variance; Animals; Arginine; Blood Pressure; Cyclic GMP; Dogs; Female; He | 2005 |
Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism.
Topics: Animals; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dogs; Drug Interactions; Female; Heart | 2006 |
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Topics: Acute Disease; Analysis of Variance; Animals; Atorvastatin; Disease Models, Animal; Drug Evaluation, | 2007 |
Nitrite in action: a commentary on "Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism".
Topics: Acute Disease; Animals; Blood Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, | 2006 |
Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism.
Topics: Acute Disease; Animals; Blood Circulation; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cons | 2006 |
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Blood Pr | 2007 |